Related Experiment Video
Updated: Apr 27, 2026
05:08
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
3.7K
The bone and fat connection in inflammatory bowel diseases
Sotirios Terzoudis1, Christos Zavos, Ioannis E Koutroubakis
1Department of Gastroenterology, University Hospital of Heraklion, Crete, Greece.
Inflammatory Bowel Diseases
|July 2, 2014
Summary
Inflammatory bowel diseases (IBD) are linked to bone loss, with fat mass and adipokines potentially playing a key role. Further research is needed to understand how these factors influence bone metabolism in IBD patients.
Area of Science:
- Bone metabolism and inflammatory bowel diseases (IBD).
- Endocrinology and metabolic disorders.
Background:
- Osteopenia and osteoporosis are frequent in IBD patients, but the exact causes of bone loss remain unclear.
- Fat mass significantly influences bone mineral density, with adipose-derived factors potentially mediating this relationship.
- The connection between adiposity and low bone density in IBD is under-researched.
Purpose of the Study:
- To explore the potential role of adipokines in the bone loss associated with inflammatory bowel diseases.
- To investigate the pathophysiological mechanisms linking adiposity, adipokines, and osteoporosis in IBD.
Main Methods:
- Review of emerging data on adipokines in IBD.
- Analysis of the relationship between fat mass, adiposity, and bone density in IBD.
- Exploration of potential mechanisms involving osteoblasts and osteoclasts.
Main Results:
- Emerging data suggest adipokines may offer a novel pathophysiological concept for bone loss in IBD.
- Adipokines might influence bone metabolism by affecting the balance between bone-forming osteoblasts and bone-resorbing osteoclasts.
Conclusions:
- Adipokines represent a promising area for understanding bone loss in IBD.
- Further studies are required to elucidate the precise role of adipokines in IBD-associated bone metabolism and osteoporosis.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
29
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
01:26Inflammatory Bowel Disease I: Introduction
34
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
34
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
27
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
27
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
29
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
29
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K